Extracellular matrix changes in knee joint cartilage following bone-active drug treatment.
Certain drugs or treatments that are known to affect bone quality or integrity might have side effects on the extracellular matrix of articular cartilage. We investigated the effects of vitamin D and calcium deficiency, estrogen deficiency, and hypercortisolism alone or in combination with bisphosphonates or sodium fluoride in an animal model, viz., the Göttingen miniature pig (n=29). The articular cartilage from knee joints was analyzed for its content of glycosaminoglycans (GAGs, as macromolecules responsible for the elasticity of articular cartilage) by a spectrometric method with dimethylene blue chloride. In cryo- or paraffin sections, alkaline phosphatase (AP, as an enzyme indicating mineralization or reorganization of articular cartilage matrix) was localized by enzyme histochemistry, and positive cells were counted, whereas differently sulfated GAGs were stained histochemically. A significant decrease in GAG content was measured in ovariectomized and long-term glucocorticoid-treated animals compared with untreated animals. In the glucocorticoid/sodium fluoride group, GAGs were significantly diminished, and significantly fewer AP-positive chondrocytes were counted compared with the control. GAG content was slightly higher, and significantly more AP-positive chondrocytes were counted in short-term glucocorticoid-treated animals then in the control group. GAGs, as part of proteoglycans, are responsible for the water-storage capacity that gives articular cartilage its unique property of elasticity. Thus, ovariectomy and long-term glucocorticoid therapy, especially when combined with sodium fluoride, have detrimental effects on this tissue.
Claassen
Horst
H
Institut für Anatomie und Zellbiologie der Martin-Luther-Universität Halle-Wittenberg, Grosse Steinstrasse 52, 06097, Halle, Germany. horst.claassen@medizin.uni-halle.de
Cellarius
Christian
C
Scholz-Ahrens
Katharina E
KE
Schrezenmeir
Jürgen
J
Glüer
Claus-Christian
CC
Schünke
Michael
M
Kurz
Bodo
B
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D050071:Bone Density Conservation Agents / Q000494:pharmacology*; D002118:Calcium / Q000172:deficiency; D002358:Cartilage, Articular / Q000187:drug effects* / Q000378:metabolism* / Q000473:pathology; D019902:Chondrocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004164:Diphosphonates / Q000494:pharmacology*; D004967:Estrogens / Q000172:deficiency; D005109:Extracellular Matrix / Q000187:drug effects* / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism; D000077557:Ibandronic Acid; D010052:Ovariectomy; D011239:Prednisolone / Q000494:pharmacology; D012969:Sodium Fluoride / Q000494:pharmacology*; D013552:Swine; D013556:Swine, Miniature; D014808:Vitamin D Deficiency / Q000378:metabolism / Q000473:pathology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D006025:Glycosaminoglycans; D012969:Sodium Fluoride; D011239:Prednisolone; D000469:Alkaline Phosphatase; D002118:Calcium; D000077557:Ibandronic Acid